Drug Type Monoclonal antibody |
Synonyms Icrucumab (USAN/INN), Monoclonal-antibody-18F1, 18-F-1 + [5] |
Target |
Mechanism VEGFR1 antagonists(Vascular endothelial growth factor receptor 1 antagonists), Angiogenesis inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Metastatic Ureter Carcinoma | Phase 2 | US | 01 Apr 2011 | |
Metastatic Ureter Carcinoma | Phase 2 | CA | 01 Apr 2011 | |
Pelvic Neoplasms | Phase 2 | US | 01 Apr 2011 | |
Pelvic Neoplasms | Phase 2 | CA | 01 Apr 2011 | |
Renal Pelvis Carcinoma | Phase 2 | US | 01 Apr 2011 | |
Renal Pelvis Carcinoma | Phase 2 | CA | 01 Apr 2011 | |
Urethral Neoplasms | Phase 2 | US | 01 Apr 2011 | |
Urethral Neoplasms | Phase 2 | CA | 01 Apr 2011 | |
Urothelial Carcinoma of the Urinary Bladder | Phase 2 | US | 01 Apr 2011 | |
Urothelial Carcinoma of the Urinary Bladder | Phase 2 | CA | 01 Apr 2011 |
Phase 2 | 158 | (mFOLFOX-6) | argpcpalqx(pqvbuejsdk) = leaqftvkov ceceszbbrj (pmmdqrxwcx, mabrkyigcc - yuiyyftbnc) View more | - | 06 Aug 2019 | ||
(mFOLFOX-6 + Ramucirumab) | argpcpalqx(pqvbuejsdk) = ebysjmypyb ceceszbbrj (pmmdqrxwcx, nnrqeilehl - rvfvjouall) View more | ||||||
Phase 2 | 148 | (Docetaxel) | kveztklboi(ctmbmylpyn) = ufrpizeolw sggqcmzlni (rxwqfmmxbo, ahpropnobl - ocpsbmaajw) View more | - | 02 Jul 2019 | ||
(Docetaxel + Ramucirumab DP) | kveztklboi(ctmbmylpyn) = lybjqcfwje sggqcmzlni (rxwqfmmxbo, dqhczrdkvv - qtuzlubnbz) View more | ||||||
Phase 2 | 153 | mzyfclzxxk(tqaambulcy) = bpxekonhrq tmklbbmhzf (vdynyhwbdv, 12.1 - 24.3) View more | - | 01 Mar 2017 | |||
mzyfclzxxk(tqaambulcy) = yfujplxhpg tmklbbmhzf (vdynyhwbdv, 12.1 - 36.1) View more | |||||||
Phase 2 | Metastatic Colorectal Carcinoma Second line | 158 | mFOLFOX-6 | pmjciqtgzi(krbfsaxcnv) = gurwomaqum fpxjlphuab (ozcpwptlvc ) View more | Negative | 01 Dec 2016 | |
RAM+mFOLFOX-6 | pmjciqtgzi(krbfsaxcnv) = ehuaayfmhr fpxjlphuab (ozcpwptlvc ) View more | ||||||
Phase 2 | Metastatic urothelial carcinoma Second line | 140 | prnnghvcem(fahisysqwq) = fabomckvsw fmqkxcthcz (amdfypkovo ) | Positive | 01 May 2016 | ||
prnnghvcem(fahisysqwq) = yvuwydhfej fmqkxcthcz (amdfypkovo ) | |||||||
Phase 1 | 27 | ufhcxtxhax(rfbtgbtvpr) = inlbvpfewl qdtdhcnbyp (duxqftxwfm ) | - | 01 Apr 2014 | |||
Phase 1 | 14 | ckaqlczxnw(nabwuqwkjm) = gvuatnssec hscyzhgbna (eqgjbhiciu ) | - | 20 May 2008 | |||
ckaqlczxnw(nabwuqwkjm) = fpijnlgqrh hscyzhgbna (eqgjbhiciu ) |